Skip to main content

Psorizide Ultra

Generic: Potassium Bromide, Nickel Sulfate, and Zinc Bromide

Verified·Apr 23, 2026
Manufacturer
Loma Lux
NDC
61480-124
Route
ORAL
ICD-10 indication
L40.0

Affordability Check

How much will you actually pay for Psorizide Ultra?

In 30 seconds, see every legitimate way to afford Psorizide Ultra — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Psorizide Ultra

Psorizide Ultra is an over-the-counter homeopathic oral medication manufactured by Loma Lux, indicated for the symptomatic relief of scaling, redness, and irritation associated with psoriasis. It utilizes a blend of homeopathic ingredients, including Potassium Bromide (Kali Bromatum), Nickel Sulfate (Niccolum Sulphuricum), and Zinc Bromide (Zincum Bromatum), to help alleviate skin symptoms. This medication is taken orally and is designed to provide non-steroidal relief for mild to moderate psoriasis symptoms.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prescribing information

From the FDA-approved label for Psorizide Ultra. Official source: DailyMed (NLM) · Label effective Jan 7, 2025

Indications and usage
INDICATIONS PSORIZIDE ® ULTRA is indicated for the treatment of moderate to severe eczema, atopic dermatitis, seborrhea and seborrheic dermatitis. It has been found to work well with variety of combination therapies. Psoriasis also responds, but generally has a more favorable response to PSORIZIDE ® Forte (NDC 61480-255-05.)
Dosage and administration
DOSAGE AND ADMINISTRATION Absorption of nickel sulphate is variable among individuals. For maximum absorption, tablets should be taken orally at the beginning of the day (or any convenient time after having taken nothing but water for at least 7 hours). Take nothing but water for one hour after taking medication to aid absorption. Weight Starting Dose Max. Dose 50-100 lbs ½ tablet 1 tablet 100-150 lbs 1 tablet 2 tablets 150-200 lbs 2 tablets 4 tablets over 200 lbs 3 tablets 6 tablets In the setting of renal impairment, dosage should be adjusted and serum nickel and bromide levels should be followed. Steady state trough level should be drawn prior to ingesting the day's dose after one week of dosing or at appropriate intervals. Target trough serum nickel level is 20-40 mcg/L. (Warning: post dose peak levels are unreliable.) Treatment duration depends on the individual. Increase dose as needed on a monthly basis. Maintenance phase In order to maintain symptomatic relief, medication may be continued at the same or reduced initial phase dose level.
Contraindications
CONTRAINDICATIONS Although there are no known contraindications, patients who are allergic to any PSORIZIDE ® ULTRA ingredient should consult a physician prior to taking the medication. (Refer to Section on Hypersensitivity )
Warnings
WARNING Do not use if imprinted seal under bottle cap is missing or broken. Do not use if pregnant or nursing. If allergic to nickel or metal objects such as jewelry or if there is a history of blistering hand eczema, see PRECAUTIONS for hypersensitivity information. Lactose intolerant patients may have gastrointestinal difficulty. This has very rarely been reported at the doses used.
Drug interactions
Drug interactions There are no known drug interactions.
Adverse reactions
ADVERSE REACTIONS PSORIZIDE ® ULTRA contains low doses of active ingredients. Therefore there are minimal known side effects. (see PRECAUTIONS for hypersensitivity information)
Use in pregnancy
Pregnancy Pregnancy category C Animal reproduction studies have not been conducted with PSORIZIDE ® ULTRA. PSORIZIDE ® ULTRA should not be given to a pregnant woman.

Label text is reproduced as-is from the FDA-approved label. We do not paraphrase, summarize, or omit. Content above is for informational purposes only and is not medical advice. Always consult your prescribing clinician or pharmacist before making decisions about your medication.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.